Oppenheimer Initiates Coverage On enGene Holdings with Outperform Rating, Announces Price Target of $30
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer has initiated coverage on enGene Holdings with an Outperform rating and set a price target of $30.
August 28, 2024 | 9:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has initiated coverage on enGene Holdings with an Outperform rating and a price target of $30, indicating a positive outlook.
The initiation of coverage with an Outperform rating and a specific price target of $30 by a reputable firm like Oppenheimer is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100